|1.||Ball, Nicholas: 1 article (02/2014)|
|2.||Kelsey, Jeffrey: 1 article (02/2014)|
|3.||Boatman, Rodney: 1 article (02/2014)|
|4.||Kamendulis, Lisa M: 1 article (07/2002)|
|5.||Klaunig, James E: 1 article (07/2002)|
|6.||Park, Joungjoa: 1 article (07/2002)|
02/01/2014 - "Hemolysis is the primary response elicited in sensitive species following EGBE administration and the proximate toxicant in this response is 2-butoxyacetic acid (BAA), the major metabolite of EGBE. "
12/01/1998 - "It is primarily metabolized in the liver to 2-butoxyacetic acid (2BAA), which is believed to be responsible for 2BE toxicities associated with hemolysis of red blood cells. "
03/01/1994 - "2-Butoxyethanol-induced hemolysis is primarily due to the effect of its metabolite 2-butoxyacetic acid (BAA). "
11/01/1994 - "These species differences in kinetics coupled with the fact that human blood is significantly less susceptible than rat blood to the hemolytic effects of 2-butoxyacetic acid indicate that there is considerably less risk for hemolysis in humans as a result of exposure to 2-butoxyethanol than would have been predicted solely from standard toxicity studies with rats."
07/01/2002 - "While the mechanism of 2-butoxyethanol-induced liver carcinogenicity has not been defined, 2-butoxyethanol has been shown to induce hemolysis in rodents via 2-butoxyacetic acid, the major metabolite of 2-butoxyethanol. "
|3.||Body Weight (Weight, Body)
11/01/1994 - "While the model predicted that rats metabolize 2-butoxyethanol and eliminate the acid metabolite faster per kilogram body weight than humans, the balance of these two processes in addition to physiological differences between species resulted in higher predicted peak blood concentrations as well as total areas under the blood concentration time curves for 2-butoxyacetic acid for rats versus humans. "
|4.||Sickle Cell Anemia (Hemoglobin S Disease)
|2.||Ethylene Glycol (Monoethylene Glycol)
|4.||Ethyl Ether (Ether)